ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
Concord Drugs Ltd reported audited consolidated net profit of ₹1.06 Crore for FY26, up from ₹0.34 Crore last year. Revenue significantly increased to ₹78.77 Crore.
Concord Drugs Ltd reported revenue from operations of ₹37.9 Cr (+264.4% YoY) and net profit of ₹0.5 Cr for Q4 FY26.
Concord Drugs Limited approved its audited financial results for the year ended March 2026. Consolidated total revenue surged significantly to ₹78.77 Crore, demonstrating strong performance.